10.25384/SAGE.7982162.v1 Sandra Vukusic Sandra Vukusic Patricia K Coyle Patricia K Coyle Stephanie Jurgensen Stephanie Jurgensen Philippe Truffinet Philippe Truffinet Myriam Benamor Myriam Benamor Salman Afsar Salman Afsar Annie Purvis Annie Purvis Elizabeth M Poole Elizabeth M Poole Christina Chambers Christina Chambers MSJ843055_supplemental_material – Supplemental material for Pregnancy outcomes in patients with multiple sclerosis treated with teriflunomide: Clinical study data and 5 years of post-marketing experience SAGE Journals 2019 Multiple sclerosis pregnancy safety teriflunomide clinical study post-marketing 2019-04-10 12:00:00 Journal contribution https://sage.figshare.com/articles/journal_contribution/MSJ843055_supplemental_material_Supplemental_material_for_Pregnancy_outcomes_in_patients_with_multiple_sclerosis_treated_with_teriflunomide_Clinical_study_data_and_5_years_of_post-marketing_experience/7982162 <p>Supplemental material, MSJ843055_supplemental_material for Pregnancy outcomes in patients with multiple sclerosis treated with teriflunomide: Clinical study data and 5 years of post-marketing experience by Sandra Vukusic, Patricia K Coyle, Stephanie Jurgensen, Philippe Truffinet, Myriam Benamor, Salman Afsar, Annie Purvis, Elizabeth M Poole and Christina Chambers in Multiple Sclerosis Journal</p>